SweetValueLab
Write for us

Eli Lilly and Company — Financial Statements & Ratios

LLY
NYSEHealthcareDrug Manufacturers - GeneralCIK 0000059478lilly.comAbout LLY
Last close · Oct 16, 20261,257.03+5.42 (+0.43%)
Market cap$1.2T

Key indicators

Revenue79.7BTTM+49.6% on a year earlier+15.0% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
24.6B 22.3B−9.1%24.5B+9.9%28.3B+15.4%28.5B+0.8%34.1B+19.6%45.0B+32.0%65.2B+44.7%79.7B+49.6%88.7B 102.7B 114.8B
— -9.1% 9.9% 15.4% 0.8% 19.6% 32.0% 44.7% 49.6% 36.2% 15.7% 11.9%
$3.13 $8.89+184.0%$6.79−23.6%$6.12−9.9%$6.90+12.7%$5.80−15.9%$11.71+101.9%$22.95+96.0%$29.80+94.8%$34.97 $47.35 $54.14
Profitability
13.2% 37.3%+24.1 pt25.2%−12.0 pt19.7%−5.5 pt21.9%+2.2 pt15.4%−6.5 pt23.5%+8.2 pt31.7%+8.2 pt33.5%+7.6 pt· · ·
32.9% 319.1%+286.2 pt109.8%−209.3 pt62.2%−47.6 pt58.6%−3.5 pt48.6%−10.0 pt74.6%+26.0 pt77.8%+3.2 pt— · · ·
Cash
4.3B 3.8B−11.9%5.1B+34.4%6.0B+16.4%5.2B−12.1%792.5M−84.8%3.8B+374.5%9.0B+138.6%18.2B+272.4%· · ·
17.6% 17.0%−0.5 pt20.8%+3.8 pt21.0%+0.2 pt18.3%−2.7 pt2.3%−16.0 pt8.3%+6.0 pt13.8%+5.4 pt22.8%+13.7 pt· · ·
2.3B 2.4B+4.2%2.7B+11.5%3.1B+14.9%3.5B+14.5%4.1B+15.1%4.7B+15.0%5.4B+15.0%— · · ·
Balance sheet
1.30x 5.88x+4.58x2.94x−2.93x1.88x−1.06x1.52x−0.36x2.34x+0.82x2.37x+0.03x1.60x−0.77x1.62x−0.56x· · ·
1.03B 935.68M−9.5%912.50M−2.5%911.68M−0.1%904.62M−0.8%903.28M−0.1%904.06M+0.1%899.30M−0.5%893.70M−0.7%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.